These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34166916)

  • 1. Multiple myeloma driving factor WHSC1 is a transcription target of oncogene HMGA2 that facilitates colon cancer proliferation and metastasis.
    Liu HH; Lee CH; Hsieh YC; Hsu DW; Cho EC
    Biochem Biophys Res Commun; 2021 Aug; 567():183-189. PubMed ID: 34166916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHSC1 promotes wnt/β-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
    Zhang J; Lu J; Chen Y; Li H; Lin L
    J Recept Signal Transduct Res; 2020 Oct; 40(5):410-418. PubMed ID: 32314642
    [No Abstract]   [Full Text] [Related]  

  • 3. MicroRNA-204-3p represses colon cancer cells proliferation, migration, and invasion by targeting HMGA2.
    Xi X; Teng M; Zhang L; Xia L; Chen J; Cui Z
    J Cell Physiol; 2020 Feb; 235(2):1330-1338. PubMed ID: 31286521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
    Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Histone Methyltransferase WHSC1 Induces Apoptosis and Inhibits Cell Proliferation and Tumorigenesis in Salivary Adenoid Cystic Carcinoma.
    Liu C; Jiang YH; Zhao ZL; Wu HW; Zhang L; Yang Z; Hoffman RM; Zheng JW
    Anticancer Res; 2019 Jun; 39(6):2729-2737. PubMed ID: 31177108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
    Kojima M; Sone K; Oda K; Hamamoto R; Kaneko S; Oki S; Kukita A; Machino H; Honjoh H; Kawata Y; Kashiyama T; Asada K; Tanikawa M; Mori-Uchino M; Tsuruga T; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Osuga Y; Fujii T
    BMC Cancer; 2019 May; 19(1):455. PubMed ID: 31092221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHSC1/NSD2 regulates immune infiltration in prostate cancer.
    Want MY; Tsuji T; Singh PK; Thorne JL; Matsuzaki J; Karasik E; Gillard B; Cortes Gomez E; Koya RC; Lugade A; Odunsi K; Battaglia S
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting
    Li J; Li T; Lu Y; Shen G; Guo H; Wu J; Lei C; Du F; Zhou F; Zhao X; Nie Y; Fan D
    FASEB J; 2017 Sep; 31(9):3774-3786. PubMed ID: 28512191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
    Yin Z; Sun Y; Ge S; Sun J
    Oncol Rep; 2017 Apr; 37(4):2286-2294. PubMed ID: 28260054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of microRNA-154 targeting WHSC1 on cell proliferation of human skin squamous cell carcinoma through mediating the P53 signaling pathway.
    Chen HQ; Gao D
    Int J Biochem Cell Biol; 2018 Jul; 100():22-29. PubMed ID: 29727714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSD2 is recruited through its PHD domain to oncogenic gene loci to drive multiple myeloma.
    Huang Z; Wu H; Chuai S; Xu F; Yan F; Englund N; Wang Z; Zhang H; Fang M; Wang Y; Gu J; Zhang M; Yang T; Zhao K; Yu Y; Dai J; Yi W; Zhou S; Li Q; Wu J; Liu J; Wu X; Chan H; Lu C; Atadja P; Li E; Wang Y; Hu M
    Cancer Res; 2013 Oct; 73(20):6277-88. PubMed ID: 23980095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
    Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
    J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dicoumarol suppresses HMGA2-mediated oncogenic capacities and inhibits cell proliferation by inducing apoptosis in colon cancer.
    Chen CH; Hsieh YC; Yang PM; Liu YR; Cho EC
    Biochem Biophys Res Commun; 2020 Apr; 524(4):1003-1009. PubMed ID: 32063361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.
    Ezponda T; Popovic R; Shah MY; Martinez-Garcia E; Zheng Y; Min DJ; Will C; Neri A; Kelleher NL; Yu J; Licht JD
    Oncogene; 2013 Jun; 32(23):2882-90. PubMed ID: 22797064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells.
    Zhang ZC; Wang GP; Yin LM; Li M; Wu LL
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6793-6800. PubMed ID: 30402842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck.
    Saloura V; Cho HS; Kiyotani K; Alachkar H; Zuo Z; Nakakido M; Tsunoda T; Seiwert T; Lingen M; Licht J; Nakamura Y; Hamamoto R
    Mol Cancer Res; 2015 Feb; 13(2):293-304. PubMed ID: 25280969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F2 induces MCM4, CCNE2 and WHSC1 upregulation in ovarian cancer and predicts poor overall survival.
    Xie L; Li T; Yang LH
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2150-2156. PubMed ID: 28537669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells.
    Shi Z; Wu D; Tang R; Li X; Chen R; Xue S; Zhang C; Sun X
    J Biosci; 2016 Jun; 41(2):229-36. PubMed ID: 27240983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
    Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
    Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.